Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of James Mcclory
Introduction
James Mcclory is a notable inventor based in Banbridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies. His work focuses on creating innovative solutions that can improve patient outcomes in cancer treatment.
Latest Patents
One of Mcclory's key patents is titled "HER-2 targeted bispecific compositions and methods for making and using the same." This patent discloses polypeptides and methods for creating bispecific antibody constructs. These constructs are covalently linked to an extended recombinant polypeptide that includes a barcode fragment, which can be released upon protease digestion. Additionally, the patent describes a Release Segment that can be cleaved proteolytically, allowing the bispecific antibody construct to be released from the extended recombinant polypeptide.
Career Highlights
James Mcclory is currently associated with Amunix Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Amunix focuses on creating innovative therapies that target specific cancer markers, enhancing the effectiveness of treatments.
Collaborations
Throughout his career, Mcclory has collaborated with several esteemed colleagues, including Volker Schellenberger and Eric Johansen. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in biotechnology.
Conclusion
James Mcclory's contributions to the field of biotechnology, particularly through his innovative patent on HER-2 targeted therapies, highlight his commitment to improving cancer treatment. His work at Amunix Pharmaceuticals, along with his collaborations, positions him as a significant figure in the ongoing quest for effective medical solutions.